Lymphoma News and Research

RSS

Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.

Arthritis drugs not as risky as first thought

Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.

8 Nov 2006

HRSA to allocate $14M to public umbilical cord blood banks

HHS' Health Resources and Services Administration plans to allocate $14 million to public umbilical cord blood banks nationwide in an effort to increase the supply of cord blood from 50,000 to 150,000 units, the AP/Washington Post reports.

17 Oct 2006

New technique allows partial-match cell transplants for children with most resistant leukemia

Clinicians at St. Jude Children's Research Hospital have successfully demonstrated an improved technique for blood stem cell transplantations in children that shows promise for those most likely to fail standard treatment for leukemia.

16 Oct 2006

FDA approves Zolinza for the treatment of cutaneous T-cell lymphoma

The U.S. Food and Drug Administration (FDA) has approved Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.

8 Oct 2006

Researchers discover clues to the cause of T-cell acute lymphoblastic leukemia

Researchers' discovery of clues to the cause of T-cell acute lymphoblastic leukemia (T-ALL) - a form of pediatric cancer that has a very poor prognosis - could lead to the development of new targeted therapies for this extremely difficult disease.

20 Sep 2006

"Allergy cells" can aggravate cancer and psoriasis

The body's mast cells are mainly associated with allergic reaction in the way they release histamine and other inflammatory substances.

13 Sep 2006

Thyroid cancer among women in the U.S. has increased

The number of new cases of thyroid cancer among women in the U.S. has increased over the past decade despite a decline among women in mortality rates for most cancers, according to a report released Wednesday by the North American Association of Central Cancer Registries, the National Cancer Institute, CDC and the American Cancer Society, Long Island Newsday reports.

7 Sep 2006

Fewer deaths from cancer in the U.S.

According to a new report fewer Americans are dying of cancer even though the rates of new cancers remains the same.

7 Sep 2006

Tumor necrosis factor A antagonist use and cancer in patients with rheumatoid arthritis

Patients with rheumatoid arthritis (RA), an autoimmune, inflammatory disease marked by progressive joint and organ damage, face a high risk of developing cancer.

31 Aug 2006

Teen wins right to refuse chemo

A teenager in the U.S. who has Hodgkins' Disease, has won a court battle which aimed to order the boy to undergo a second course of intensive chemotherapy.

20 Aug 2006

Leukemia gene changes genetic packaging

A signaling system involved in many forms of leukemia and lymphoma is more powerful than scientists have thought, exerting control over our genes by affecting whole swaths of chromosomes in global fashion.

6 Aug 2006

Turning the immune system against cancer

Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays.

4 Aug 2006

Belfer Foundation funds new translational cancer institute

The Arthur and Rochelle Belfer Foundation has pledged $8 million to create the Arthur and Rochelle Belfer Institute of Hematology and Medical Oncology at Weill Medical College of Cornell University.

25 Jul 2006

Early menopause on the cards for childhood cancer survivors

In a new study researchers have found that girls who survive childhood cancer are more likely to experience an early menopause when they mature than other women.

6 Jul 2006

Women who survive childhood cancer are more likely to suffer premature menopause

Women who survive childhood cancer are more likely to suffer premature menopause, according to a study in the July 5 issue of the Journal of the National Cancer Institute.

4 Jul 2006

Burkitt lymphoma gene expression signature identified

An international research study involving the University of Nebraska Medical Center, the National Cancer Institute and 10 other institutions has successfully identified the gene expression signature for Burkitt lymphoma.

14 Jun 2006

Is there an increased risk of other malignancies in patients with renal cell carcinoma?

There have been conflicting reports in the literature regarding the association of other malignancies with renal cell carcinoma (RCC).

14 Jun 2006

New data show Enzastaurin's activity across multiple cancer cell lines

Eli Lilly and Company's enzastaurin, an investigational, multi-targeted therapy that is currently the focus of two global Phase III clinical trials, one for the treatment of glioblastoma and one in non-Hodgkin's lymphoma

5 Jun 2006

Arthritis drug wins approval for use in children with Crohn's disease

The Food and Drug Administration in the U.S. has given approval for the drug Remicade for use in children with active Crohn's disease(CD), a chronic and debilitating condition.

21 May 2006

Study sheds light on cancer susceptibility and disease involving bone-marrow failure

Defective protein production can occur in cells even when the genes controlling those proteins are normal, according to a new study to be published May 12 in Science.

12 May 2006